drugs glp-1 The Revolution: How Drugs Work for Weight Loss As GLP-1 drugs go mainstream,
Description
Our findings align with and extend existing literature on integrating digital interventions with pharmacological treatments for obesity
Pedersen, S.D
Subsequent studies revealed that co-infusion of GLP-1 with GCG can mitigate the GCG-induced hyperglycaemia [34], while preserving GCGs metabolic benefits, providing a strong rationale for the development of GLP1/GCG co-agonists as obesity treatments (Fig
Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study
